Showing results (51-60 of 75) with videos related to
Sort By:
Pageof 8
Patient Education and Counseling|September 15, 2022
"You're more engaged when you're listening to somebody tell their story": A qualitative exploration into the mechanisms of the podcast 'menopause: unmuted' for communicating health informationPhilippa A Shaw, Amy L Sumner, Candida C Halton, et al.Investigative Ophthalmology & Visual Science|March 1, 1994
Complement system and host defense against staphylococcal endophthalmitisM J Giese, B J Mondino, B J Glasgow, et al.Journal of Dairy Science|October 26, 2021
Dairy farmers' perspectives on providing cow-calf contact in the pasture-based systems of New ZealandHeather W Neave, Christine L Sumner, Roxanne J T Henwood, et al.Trials|September 29, 2022
A randomized, double-blind, placebo-controlled, hybrid parallel-arm study of low-dose naltrexone as an adjunctive anti-inflammatory treatment for major depressive disorderJulia R Plank, Stephanie C Glover, Ben D Moloney, et al.Clinical Nephrology|March 30, 2007
Chronic myeloid leukemia-associated membranoproliferative glomerulonephritis that responded to imatinib mesylate therapyJ P Dwyer, K M Yates, E L Sumner, et al.Journal of Diabetes Science and Technology|May 31, 2014
Short-Term Thermal-Humidity Shock Affects Point-of-Care Glucose Testing: Implications for Health Professionals and PatientsMandy Lam, Richard F Louie, Corbin M Curtis, et al.Trials|February 12, 2020
A randomised, double-blind, active placebo-controlled, parallel groups, dose-response study of scopolamine hydrobromide (4-6 μg/kg) in patients with major depressive disorderJoseph C C Chen, Rachael L Sumner, Venkat Krishnamurthy Naga, et al.Frontiers in Pharmacology|March 23, 2026
Low-dose naltrexone as an adjunctive treatment for major depressive disorder: findings from a randomized, double-blind, placebo-controlled hybrid parallel-arm studyBen D Moloney, Anna Forsyth, Rachael L Sumner, et al.Trials|April 24, 2021
MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteersRobin J Murphy, Rachael L Sumner, William Evans, et al.Therapeutic Advances in Psychopharmacology|December 9, 2025
What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trialCarina Joy Donegan, Dimitri Daldegan-Bueno, Rachael L Sumner, et al.Pageof 8